Trial intelligence / Profile preview

Therapeutic Equivalence of Estradiol Vaginal Cream in Atrophic Vaginitis

NCT02995694Phase 3Completed

Sponsor
Alvogen
Start
Mar 2016
Primary completion
Dec 2016
01

Overview

Phase 3, randomised, double-blind trial of estradiol topical in atrophic vaginitis (3 arms), sponsored by Alvogen. Primary endpoint: Vaginal Cytology at Day 8. Started Mar 2016; status: completed.

02

Drugs

estradiol topical
03

Conditions

atrophic vaginitis

Beyond the preview

Go deeper on NCT02995694.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02995694.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call